We are live on ! Find out more
FMTX

Forma Therapeutics Holdings, Inc. Common Stock
FMTX

Delisted

FMTX was delisted on the 13th of October, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in Forma Therapeutics Holdings, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 137 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 139 → 0 (-139)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $835M → $0 (-$835M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 137

Holders
–
Holders Change
-139
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
137
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$180M
2
BlackRock
BlackRock
New York
-$72.5M
3
BBA
Baker Bros. Advisors
New York
-$37.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$37.2M
5
TAL
TIG Advisors LLC
New York
-$26.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
– -$180M -9,011,651 Closed
BlackRock
2
BlackRock
New York
– -$72.5M -3,632,271 Closed
BBA
3
Baker Bros. Advisors
New York
– -$37.6M -1,886,760 Closed
Vanguard Group
4
Vanguard Group
Pennsylvania
– -$37.2M -1,865,281 Closed
TAL
5
TIG Advisors LLC
New York
– -$26.1M -1,305,794 Closed
WIC
6
Water Island Capital
New York
– -$25M -1,253,785 Closed
AAM
7
Alpine Associates Management
Florida
– -$22.8M -1,140,500 Closed
HA
8
HHLR Advisors
Cayman Islands
– -$21.9M -1,100,000 Closed
SB
9
Samsara BioCapital
California
– -$21.3M -1,065,413 Closed
FTCM
10
First Trust Capital Management
Illinois
– -$20.5M -1,029,333 Closed
Balyasny Asset Management
11
Balyasny Asset Management
Illinois
– -$20.1M -1,005,734 Closed
Man Group
12
Man Group
United Kingdom
– -$19.4M -970,598 Closed
DTC
13
Deep Track Capital
Connecticut
– -$19.3M -966,573 Closed
State Street
14
State Street
Massachusetts
– -$19M -951,871 Closed
Morgan Stanley
15
Morgan Stanley
New York
– -$15M -751,051 Closed
NAM
16
Nexpoint Asset Management
Texas
– -$14.4M -720,851 Closed
BSCM
17
Berry Street Capital Management
United Kingdom
– -$14.3M -717,500 Closed
Geode Capital Management
18
Geode Capital Management
Massachusetts
– -$14M -701,849 Closed
Renaissance Technologies
19
Renaissance Technologies
New York
– -$14M -700,100 Closed
GCL
20
Glazer Capital LLC
New York
– -$12.1M -607,345 Closed
SSA
21
Schonfeld Strategic Advisors
New York
– -$10.9M -546,891 Closed
JP Morgan Chase
22
JP Morgan Chase
New York
– -$10.8M -543,781 Closed
PMAM
23
Picton Mahoney Asset Management
Ontario, Canada
– -$7.7M -386,135 Closed
AllianceBernstein
24
AllianceBernstein
Tennessee
– -$7.5M -375,864 Closed
Northern Trust
25
Northern Trust
Illinois
– -$6.99M -350,530 Closed
1
2 3 4 5

FMTX Hedge Fund Activity: Q4 2022 in Review

0 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Forma Therapeutics Holdings, Inc. Common Stock (FMTX) for Q4 2022, worth a combined $0 — down 100% from $835M a quarter earlier.

Sellers outnumbered buyers: 137 funds closed out of FMTX and 0 opened new positions — a net loss of 137 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was RA Capital Management, exiting entirely with an estimated $180M sold.

  • 0 institutional investors held Forma Therapeutics Holdings, Inc. Common Stock (FMTX) as of Q4 2022, down from 139 in Q3 2022.
  • Funds reported $0 of Forma Therapeutics Holdings, Inc. Common Stock stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Forma Therapeutics Holdings, Inc. Common Stock positions in Q4 2022 and 137 closed out, a net change of -137 holders.
  • The largest Forma Therapeutics Holdings, Inc. Common Stock seller in Q4 2022 was RA Capital Management, an estimated $180M sold.

Based on aggregated 13F filings for Q4 2022.